期刊文献+

静脉注射造影剂对妇科肿瘤全盆腔放疗剂量分布的影响 被引量:2

Effect of intravenous contrast agent on dose distribution in treatment planning for postoperative whole pelvic radiotherapy of gynecologic cancer
下载PDF
导出
摘要 目的探讨静脉注射造影剂对妇科肿瘤术后全盆腔放疗剂量分布的影响。方法选择10例接受术后全盆腔放疗的子宫内膜癌和子宫颈癌患者。对每例患者静脉注射造影剂前后相同体位下行CT模拟定位扫描,在平扫图像和增强图像上为每例患者设计相同的三维适形全盆腔放疗计划。比较两组计划靶区、危及器官和正常组织剂量分布。结果增强计划的靶区、危及器官和正常组织平均剂量均低于平扫计划,但两组计划间差异均<1.0Gy,危及器官和正常组织最大剂量差异均<2.0 Gy,差异均无统计学意义。结论静脉注射造影剂对妇科肿瘤术后全盆腔适形放疗剂量分布影响很小,临床上可以忽略。 Objective To evaluate the effect of intravenous contrast agent on dose distribution in postoperative whole pelvic radiotherapy(WPRT) plans for gynecologic cancers.Methods Ten endometrial and cervical cancer patients undergoing postoperative WPRT were enrolled.Two sets of computerized tomography(CT) images were acquired in the same position before and after intravenous contrast agent injections.Three dimensional WPRT plans were created for each patient on the non-enhanced CT and enhanced CT.The dose distribution calculated from the two sets of CTs was compared with regard to planning target volumes(PTV),OARs and normal tissue.Results The doses calculated from the enhanced CTs were lower than those from the non-enhanced CTs,but the differences of mean dose to PTV,OARs and normal tissue were less than 1.0 Gy,the differences of the maximum dose to OARs and normal tissue were less than 2.0 Gy.The differences were not statistically significant between the non-enhanced and enhanced CTs.Conclusion Planning from CT scans with intravenous contrast agent results in tolerably small errors clinically for postoperative three-dimensional conformal WPRT.
出处 《实用肿瘤杂志》 CAS 北大核心 2010年第3期311-314,共4页 Journal of Practical Oncology
关键词 生殖器肿瘤 女(雌)性 放射疗法 适形 剂量效应关系 辐射 造影剂 计算机体层摄影术 genital neoplasms female radiotherapy conformal dose-response relationship radiation contrast media tomography X-ray computed
  • 相关文献

参考文献12

  • 1张翔,俞华.盆腔淋巴结分布与子宫颈癌常规盆腔照射野的关系[J].实用肿瘤杂志,2009,24(4):385-388. 被引量:1
  • 2Casas F, Vinolas N, Sanchez-Reyes A, et al. Spanish patterns of care for 3D radiotherapy in non-small cell lung cancer [ J ]. Int J Radiat Oncol Biol Phys,2006,65 (4) : 9O7 - 916.
  • 3Liauw SL, Amdur R J, Mendenhall WM, et al. The effect of intravenous contrast on intensity-modulated radiation therapy dose calculations for head and neck cancer [ J ]. Am J Clin Oncol,2005,28(5) :456 -459.
  • 4Choi Y, Kim JK, Lee HS, et al. Influence of intravenous contrast agent on dose calculations of intensity modulated radiation therapy plans for head and neck cancer [ J ]. Radiother Oncol,2006,81 (2) : 158 - 162.
  • 5Lee FK, Chan CC, Law CK. Influence of CT contrast agent on dose calculation of intensity modulated radiation therapy plan for nasopharyngeal carcinoma [ J ]. J Med Imaging Radiat Oncol,2009,53 ( 1 ) : 114 - 118.
  • 6Letoumeau D, Finlay M, O'Sullivan B, et al. Lack of influence of intravenous contrast on head and neck IMRT dose distributions [ J ]. Acta Oncol, 2008,47 ( 1 ) : 90 - 94.
  • 7Lees J, Holloway L, Fuller M, et al. Effect of intravenous contrast on treatment planning system dose calculations in the lung [J]. Australas Phys Eng Sci Med,2005,28(3) : 190 - 195.
  • 8杨焕军,蒋国梁,傅小龙,钱浩,陈兰飞,丘健建,王孝深,梁世雄.肺癌CT增强定位扫描对放疗的剂量影响[J].中华放射肿瘤学杂志,2005,14(3):216-217. 被引量:13
  • 9Shibamoto Y, Naruse A, Fukuma H, et al. Influence of contrast materials on dose calculation in radiotherapy planning using computed tomography for tumors at various anatomical regions: a prospective study [ J ]. Radiother Oncol,2007,84( 1 ) :52 -55.
  • 10Ramm U, Damrau M, Mose S, et al. Influence of CT contrast agents on dose calculations in a 3D treatment planning system [ J ]. Phys Med Biol, 2001,46 ( 13 ) : 2631 - 2635.

二级参考文献9

  • 1Bonin SR,Lanciano RM,Corn BW,et al.Bony landmarks are not an adequate substitute for lymphangiography in defining pelvic lymph node location for the treatment of cervical cancer with radiotherapy[J].Int J Radiat Oncol Biol Phys,1996,34(1):167-172.
  • 2Greer BE,Koh WJ,Figge DC,et al.Gynecologic radiotherapy fields defined by intraoperative measurements[J].Gynecol Oncol,1990,38(3):421-424.
  • 3Eifel PJ,Winter K,Morris M,et al.Pelvic irradiation with concurrent chemotherapy versus pelvic and paraaortic irradiation for high-risk cervical cancer:an update of radiation therapy oncology group trial (RTOG) 90-01[J].J Clin Oncol,2004,22(5):872-880.
  • 4Pearcey R,Brundage M,Drouin P,et al.Phase Ⅲ trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix[J].J Clin Oncol,2002,20(4):966-972.
  • 5McAlpine J,Schlaerth JB,Lim P,et al.Radiation fields in gynecologic oncology:correlation of soft tissue (surgical) to radiologic landmarks[J].Gynecol Oncol,2004,92(1):25-30.
  • 6Zunino S,Rosato O,Lucino S,et al.Anatomic study of the pelvis in carcinoma of the uterine cervix as related to the box technique[J].Int J Radiat Oncol Biol Phys,1999,44(1):53-59.
  • 7Finlay MH,Ackerman I,Tirona RG,et al.Use of CT simulation for treatment of cervical cancer to assess the adequacy of lymph node coverage of conventional pelvic fields based on bony landmarks[J].Int J Radiat Oncol Biol Phys,2006,64(1):205-209.
  • 8Pendlebury SC,Cahill S,Crandon AJ,et al.Role of bipedal lymphangiogram in radiation treatment planning for cervix cancer[J].Int J Radiat Oncol Biol Phys,1993,27(4):959-962.
  • 9Chao KS,Lin M.Lymphangiogram-assisted lymph node target delineation for patients with gynecologic malignancies[J].Int J Radiat Oncol Biol Phys,2002,54(4):1147-1152.

共引文献12

同被引文献9

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部